Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial

from Oncology Learning Network · host HMP Global

Petros Grivas, MD, PhD, discusses the combination of sacituzumab govetican and pembrolizumab for metastatic urothelial carcinoma in the second-line setting.

Episode metadata supplied by the publisher feed · Published Mar 7, 2024

Embed this episode

Attribution link and audio player

Ready to play

Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial

0:00 7:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 7 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on March 7, 2024.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!